Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
short-term repeated dose toxicity: other route
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
1988
Reliability:
3 (not reliable)
Rationale for reliability incl. deficiencies:
other: Review data only.

Data source

Reference
Reference Type:
review article or handbook
Title:
VCVN1* "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inorganic substances containing I-IV group elements)
Author:
Filov V.A.
Year:
1988
Bibliographic source:
Chimia, 1988, page 351

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Public available literature. No guideline indicated. For details on method see materials and methods section.
GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Sodium cyanate
EC Number:
213-030-6
EC Name:
Sodium cyanate
Cas Number:
917-61-3
Molecular formula:
CNO.Na
IUPAC Name:
sodium cyanate
Details on test material:
no details given

Test animals

Species:
monkey
Strain:
not specified
Sex:
not specified
Details on test animals or test system and environmental conditions:
not indicated.

Administration / exposure

Route of administration:
subcutaneous
Vehicle:
not specified
Details on exposure:
not indicated.
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
60 days
Frequency of treatment:
not indicated.
Doses / concentrations
Remarks:
Doses / Concentrations:
not indicated.
No. of animals per sex per dose:
not indicated.
Control animals:
not specified
Details on study design:
not indicated.

Examinations

Observations and examinations performed and frequency:
not indicated.
Sacrifice and pathology:
not indicated.
Other examinations:
not indicated.
Statistics:
not indicated.

Results and discussion

Results of examinations

Clinical signs:
not specified
Mortality:
not specified
Body weight and weight changes:
not specified
Food consumption and compound intake (if feeding study):
not specified
Food efficiency:
not specified
Water consumption and compound intake (if drinking water study):
not specified
Ophthalmological findings:
not specified
Haematological findings:
not specified
Clinical biochemistry findings:
not specified
Urinalysis findings:
not specified
Behaviour (functional findings):
effects observed, treatment-related
Organ weight findings including organ / body weight ratios:
not specified
Gross pathological findings:
not specified
Histopathological findings: non-neoplastic:
not specified
Histopathological findings: neoplastic:
not specified
Details on results:
Spinal Cord - meningeal changes

Effect levels

Key result
Dose descriptor:
other: TDLo - Lowest published toxic dose
Effect level:
1 500 other: mg/kg/60 days
Based on:
test mat.
Sex:
not specified
Basis for effect level:
other: Spinal Cord - meningeal changes equivalent to 25 mg/kg bw/day

Applicant's summary and conclusion

Conclusions:
The TDLo (lowest published toxic dose) = 1500 mg/kg/ 60 days equivalent to 25 mg/kg bw/day (intermittent).
Executive summary:

In a subacute toxicity study sodium cyanate was administered to monkeys subcutaneous for 60 days.

Effects: Spinal Cord - meningeal changes

The TDLo (lowest published toxic dose) = 1500 mg/kg/ 60 days equivalent to 25 mg/kg bw/day (intermittent).

This subacute study in the rat is acceptable, as supporting study.